M. Flesch et al., Effects of endotoxin on human myocardial contractility involvement of nitric oxide and peroxynitrite, J AM COL C, 33(4), 1999, pp. 1062-1070
Citations number
40
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
OBJECTIVES This study examined the effects of endotoxin on cardiac contract
ility in human myocardium.
BACKGROUND In animal myocardium, endotoxin and cytokine treatment led to en
hanced inducible nitric oxide synthase (iNOS) expression and contractile dy
sfunction. Effects in human myocardium are unknown.
METHODS Left ventricular myocardial preparations from failing (n = 18) and
nonfailing (n = 5) human hearts were incubated for 6 and 12 h in tyrode sol
ution or in tyrode plus lipopolysaccharides (LPS), with LPS plus N-G-mono-m
ethyl-L-arginine (L-NMMA), with LPS plus hemoglobin or with LPS plus the su
peroxide scavenger 4,5-dihydroxy-1,3-benzene disulfonic acid (Tiron). Force
of contraction in response to isoprenaline (0.001 to 3 mu mol/liter) was d
etermined in electrically stimulated muscle preparations. The iNOS mRNA exp
ression was examined by in situ hybridization and by polymerase chain react
ion. The cyclic guanosine monophosphate (cGMP) levels were determined by ra
dioimmunoassay.
RESULTS Isoprenaline concentration dependently increased force of contracti
on. Six and 12 hours of LPS treatment of failing myocardium decreased maxim
um inotropic response to isoprenaline by 54% (p = 0.009) and by 69% (p = 0.
0023), respectively. In nonfailing myocardium, 12 h of LPS treatment decrea
sed maximum inotropic effect of isoprenaline by 66% (p < 0.001). The LPS ef
fects were attenuated by L-NMMA, hemoglobin and also Tiron. The iNOS mRNA w
as expressed in all LPS-treated preparations but also in most control myoca
rdial preparations. In situ hybridization revealed iNOS expression within c
ardiac myocytes. There nas no increase in myocardial cGMP content in respon
se to endotoxin.
CONCLUSIONS Endotoxin exposure of human myocardium leads to a depression of
cardiac contractility, which is mediated by enhanced iNOS activity and rel
ease of nitric oxide (NO). Consecutive reaction of NO with superoxide and f
ormation of peroxynitrite may contribute to the decrease in force of contra
ction. (J Am Coll Cardiol 1999;33:1062-70) (C) 1999 by the American College
of Cardiology.